 The main purpose of this study is to demonstrate that dapaconazole cream 2 experimental drug is non-inferior to ketoconazole cream 2 Nizoral - active comparator for the treatment of dermatological lesions of Tinea pedis, when applied to the skin topically once daily during 28 days. Additionally, the safety and tolerability aspects will be evaluated in a descriptive way, through the observation of the incidence of adverse events. 